Dexmal Seeks $3 Billion Funding Valuation
Chinese robotics startup Dexmal is seeking a valuation of about 20 billion yuan ($3 billion) in an ongoing funding round on August 21, 2026, founder Tang Wenbin told Bloomberg News. The talks follow a previous round involving Zhipu, while Dexmal said Alibaba and NIO Capital led rounds late last year.
Chinese robotics startup Dexmal is seeking a valuation of about 20 billion yuan ($3 billion) in an ongoing funding round, founder Tang Wenbin told Bloomberg News at the World Robot Conference in Beijing. The reported valuation is a target in active fundraising discussions, not a completed financing valuation.
Funding history and sector context
Bloomberg reports that the talks follow a previous Dexmal round that included Chinese AI lab Zhipu, also known as Zhipu AI. According to Dexmal, funding rounds late last year were led by Alibaba and NIO Capital.
PYMNTS, citing Bloomberg, describes Dexmal as a company developing embodied AI to control robots. Bloomberg framed the fundraising as evidence of investor interest in Chinese companies pursuing advances in physical AI, a term commonly used for AI systems connected to perception, action, and real-world robotic hardware.
The available reporting does not identify the amount Dexmal is raising, prospective investors in the current round, or the terms under discussion beyond the reported valuation target.
What the valuation target means
A sought valuation and a closed valuation are distinct: Bloomberg reports that Dexmal's discussions remain ongoing. For teams tracking embodied-AI vendors, the eventual terms would provide a more concrete signal about capital availability for robotics stacks that combine learned control software with expensive hardware development and deployment.
Across comparable robotics investments, practitioners typically look beyond headline valuation to deployment evidence, including reliability in unstructured environments, data collection and simulation workflows, safety mechanisms, and unit economics. Those details were not disclosed in the reporting on Dexmal's current round.
Key Points
- 1Dexmal is seeking a 20 billion yuan valuation in an ongoing round, but the reported fundraising amount and final terms remain undisclosed.
- 2Bloomberg reports prior Dexmal funding involved Zhipu, Alibaba, and NIO Capital, linking the startup to major Chinese AI and technology investors.
- 3In embodied-AI financing, valuation headlines provide limited technical evidence; comparable deployments are commonly assessed through reliability, safety, data, and hardware economics.
Scoring Rationale
The reported $3 billion valuation target is notable financing news in the fast-growing embodied-AI and robotics market. However, the round remains in discussion and reporting does not disclose a funding amount, technical product details, or deployment metrics.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
